Article
TP53 Deficiency in the Natural History of Prostate Cancer
14 Feb 2025
Abstract excerpt
Prostate cancer remains a leading cause of cancer-related mortality in men, with advanced stages posing significant treatment challenges due to high morbidity and mortality. Among genetic alterations, TP53 mutations are among the most prevalent in cancers and are strongly associated with poor clinical outcomes and therapeutic resistance. This review investigates the role of TP53 mutations in prostate cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
